Pyruvate dehydrogenase as a therapeutic target for obesity cardiomyopathy (Q38652550)

5 September 2017

title

Pyruvate dehydrogenase as a therapeutic target for obesity cardiomyopathy (English)

1 reference

5 September 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26617082%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Andrew Jm Lewis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26617082%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Stefan Neubauer

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26617082%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Oliver J Rider

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26617082%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

English

0 references

publication date

28 November 2015

1 reference

Expert Opinion on Therapeutic Targets

5 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26617082%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26617082%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26617082%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

755-766

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26617082%20AND%20SRC:MED&resulttype=core&format=json

Obesity and the risk of heart failure

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Trends in prevalence and outcome of heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Cardiac remodeling in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

The failing heart--an engine out of fuel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

The origin of modern metabolic networks inferred from phylogenomic analysis of protein architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Cardiac energy metabolism in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

PPAR signaling in the control of cardiac energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Influence of body fat distribution on free fatty acid metabolism in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Regional myocardial free fatty acid extraction in normal and ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Lipotoxic heart disease in obese rats: implications for human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Altered promoter methylation of PDK4, IL1 B, IL6, and TNF after Roux-en Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Cardiac carbohydrate metabolism in Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Increased myocardial uptake of dietary fatty acids linked to cardiac dysfunction in glucose-intolerant humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Reduced PDK4 expression associates with increased insulin sensitivity in postobese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Effect of caloric restriction on myocardial fatty acid uptake, left ventricular mass, and cardiac work in obese adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Successful weight reduction improves left ventricular diastolic function and physical performance in severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Lowering body weight in obese mice with diastolic heart failure improves cardiac insulin sensitivity and function: implications for the obesity paradox.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Tissue-specific pyruvate dehydrogenase complex deficiency causes cardiac hypertrophy and sudden death of weaned male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Chronic Inhibition of Pyruvate Dehydrogenase in Heart Triggers an Adaptive Metabolic Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Mechanisms for insulin resistance: common threads and missing links

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Rapid inhibition of pyruvate dehydrogenase: an initiating event in high dietary fat-induced loss of metabolic flexibility in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Effects of weight loss on myocardial energetics and diastolic function in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Importance of free fatty acids as a determinant of myocardial oxygen consumption and myocardial ischemic injury during norepinephrine infusion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Myocardial infarction and heart failure in the db/db diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment an

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

The pathophysiology of diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Is the failing heart energy starved? On using chemical energy to support cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Uncoupling proteins in human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

UCP3 regulates cardiac efficiency and mitochondrial coupling in high fat-fed mice but not in leptin-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Hypoxia-induced decrease of UCP3 gene expression in rat heart parallels metabolic gene switching but fails to affect mitochondrial respiratory coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Lack of UCP3 does not affect skeletal muscle mitochondrial function under lipid-challenged conditions, but leads to sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

High fat, high sucrose diet causes cardiac mitochondrial dysfunction due in part to oxidative post-translational modification of mitochondrial complex II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Effect of Free Fatty Acids on Myocardial Function and Oxygen Consumption in Intact Dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Cardiac lipid accumulation associated with diastolic dysfunction in obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust core-free basal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Metabolic Effects of Dichloroacetate in Patients with Diabetes Mellitus and Hyperlipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Human Polymorphisms in the Glutathione Transferase Zeta 1/Maleylacetoacetate Isomerase Gene Influence the Toxicokinetics of Dichloroacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Phenylbutyrate therapy for pyruvate dehydrogenase complex deficiency and lactic acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Structure-guided Development of Specific Pyruvate Dehydrogenase Kinase Inhibitors Targeting the ATP-binding Pocket

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Treatment with the 3-ketoacyl-CoA thiolase inhibitor trimetazidine does not exacerbate whole-body insulin resistance in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Trimetazidine prevents palmitate-induced mitochondrial fission and dysfunction in cultured cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

The biology of incretin hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

CD36 Deficiency Rescues Lipotoxic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

Effects of Catecholamine Stress on Diastolic Function and Myocardial Energetics in Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2016.1126248

10.1517/14728222.2016.1126248

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26617082%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26617082%20AND%20SRC:MED&resulttype=core&format=json